Tecar Therapy in Chronic Knee Osteoarthritis
Starting soon · Not applicable · Has a placebo group
Conditions studied: Osteearthritis
In brief
This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.
Key facts
- Study ID
- NCT07438392
- Run by
- Kirsehir Ahi Evran Universitesi
- People needed
- 60
- Starts
- 2026-04-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-03-02
Who can join
Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis
- Patients with bilateral knee pain for at least 6 weeks
- Male and female patients aged 40-75
- Patients who accept and sign the informed consent form
You may not qualify if…
- Those who have received physical therapy for knee pain in the last 6 months
- Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months
- Those who have undergone knee surgery for any reason
- Those with inflammatory arthritis
- Those with existing neurological, cognitive, or psychiatric disorders
- Those with pacemakers
- Those with a history of malignancy
- Those with local vascular or sensory impairment
- Those with local or systemic infections
- Those with open wounds on the skin
- Pregnant or breastfeeding
Where it is running
- Kırşehir Ahi Evran Üniversitesi — Kırşehir, Kırşehir, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.